Close this search box.

SRT-100™ is an Optimal Therapy Modality for Non-Melanoma Skin Cancers

February 13, 2014

Featuring our SharpBeam precision superficial radiotherapy, the SRT-100™ is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100™ when you weigh your treatment options!